Cleared Traditional

K210558 - LiteAire Basic Dual-Valved, Collapsible MDI Holding Chamber (FDA 510(k) Clearance)

Apr 2022
Decision
400d
Days
Class 2
Risk

K210558 is an FDA 510(k) clearance for the LiteAire Basic Dual-Valved, Collapsible MDI Holding Chamber. This device is classified as a Holding Chambers, Direct Patient Interface (Class II - Special Controls, product code NVP).

Submitted by Thayer Medical Corporation (Tucson, US). The FDA issued a Cleared decision on April 1, 2022, 400 days after receiving the submission on February 25, 2021.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5630. Holding Chambers Are Devices That Are Used With Nebulizers And Metered Dose Inhalers And Are Comprised Of A Reservoir Into Which An Aerosol Medication Is Dispensed. A Holding Chamber Uses A Valved Mouthpiece Through Which The Patient Inhales The Dispensed Medication. Holding Chambers Are Intended To Minimize Delivery Of Large Aerosolized Particles.

Submission Details

510(k) Number K210558 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 25, 2021
Decision Date April 01, 2022
Days to Decision 400 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code NVP - Holding Chambers, Direct Patient Interface
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.5630
Definition Holding Chambers Are Devices That Are Used With Nebulizers And Metered Dose Inhalers And Are Comprised Of A Reservoir Into Which An Aerosol Medication Is Dispensed. A Holding Chamber Uses A Valved Mouthpiece Through Which The Patient Inhales The Dispensed Medication. Holding Chambers Are Intended To Minimize Delivery Of Large Aerosolized Particles